(0.09%) 5 522.00 points
(0.12%) 39 891 points
(0.22%) 19 794 points
(0.01%) $81.64
(0.46%) $2.82
(-0.32%) $2 336.80
(-0.03%) $29.52
(0.21%) $1 003.90
(0.02%) $0.932
(0.00%) $10.53
(0.01%) $0.788
(-0.85%) $87.25
9.02% $ 6.89
Live Chart Being Loaded With Signals
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company\'s flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease...
Stats | |
---|---|
Dzisiejszy wolumen | 48 619 |
Średni wolumen | 60 835 |
Kapitalizacja rynkowa | 246.58M |
EPS | $-0.380 ( Q1 | 2024-05-13 ) |
Następna data zysków | ( $-0.420 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-4.72 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0520 (0.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Connealy Pamela Ann | Buy | 5 376 | Common Stock, par value $0.0001 per share ("Common Stock") |
2024-06-20 | Connealy Pamela Ann | Buy | 17 068 | Stock Option (Right to Buy) |
2024-06-20 | Aryeh Jason | Buy | 5 376 | Common Stock, par value $0.0001 per share ("Common Stock") |
2024-06-20 | Aryeh Jason | Buy | 17 068 | Stock Option (Right to Buy) |
2024-06-20 | Rose Eric A Md | Buy | 17 068 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 99 transactions |
Buy: 5 227 450 | Sell: 0 |
Wolumen Korelacja
Orchestra BioMed Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Orchestra BioMed Korelacja - Waluta/Towar
Orchestra BioMed Finanse
Annual | 2023 |
Przychody: | $2.76M |
Zysk brutto: | $2.43M (88.06 %) |
EPS: | $-1.480 |
FY | 2023 |
Przychody: | $2.76M |
Zysk brutto: | $2.43M (88.06 %) |
EPS: | $-1.480 |
FY | 2022 |
Przychody: | $3.53M |
Zysk brutto: | $3.21M (90.89 %) |
EPS: | $-2.24 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Orchestra BioMed
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company\'s flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej